Royal Bank of Canada’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-831,958
Closed -$153M 7529
2021
Q2
$153M Buy
831,958
+577,678
+227% +$106M 0.04% 344
2021
Q1
$38.9M Buy
254,280
+11,668
+5% +$1.78M 0.01% 748
2020
Q4
$37.9M Buy
242,612
+116,578
+92% +$18.2M 0.01% 715
2020
Q3
$14.4M Buy
126,034
+68,586
+119% +$7.85M 0.01% 1137
2020
Q2
$6.45M Buy
57,448
+14,132
+33% +$1.59M ﹤0.01% 1561
2020
Q1
$3.89M Sell
43,316
-61,358
-59% -$5.51M ﹤0.01% 1729
2019
Q4
$11.3M Sell
104,674
-8,362
-7% -$904K ﹤0.01% 1317
2019
Q3
$11.1M Sell
113,036
-32,104
-22% -$3.14M ﹤0.01% 1267
2019
Q2
$19M Buy
145,140
+17,659
+14% +$2.31M 0.01% 980
2019
Q1
$17.2M Buy
127,481
+5,324
+4% +$720K 0.01% 1006
2018
Q4
$11.9M Buy
122,157
+13,421
+12% +$1.31M 0.01% 1106
2018
Q3
$15.1M Buy
108,736
+31,221
+40% +$4.32M 0.01% 1111
2018
Q2
$9.62M Sell
77,515
-57,258
-42% -$7.11M ﹤0.01% 1317
2018
Q1
$15M Buy
134,773
+17,291
+15% +$1.93M 0.01% 1087
2017
Q4
$14.1M Sell
117,482
-30,558
-21% -$3.65M 0.01% 1142
2017
Q3
$20.8M Buy
148,040
+25,356
+21% +$3.56M 0.01% 889
2017
Q2
$14.9M Sell
122,684
-61,091
-33% -$7.43M 0.01% 1034
2017
Q1
$22.3M Buy
183,775
+798
+0.4% +$96.8K 0.01% 809
2016
Q4
$22.4M Buy
182,977
+23,778
+15% +$2.91M 0.01% 825
2016
Q3
$19.5M Buy
159,199
+53,054
+50% +$6.5M 0.01% 857
2016
Q2
$12.4M Buy
106,145
+6,594
+7% +$770K 0.01% 1092
2016
Q1
$13.9M Sell
99,551
-44,837
-31% -$6.24M 0.01% 1009
2015
Q4
$27.5M Buy
144,388
+73,702
+104% +$14.1M 0.02% 650
2015
Q3
$11.1M Sell
70,686
-49,541
-41% -$7.75M 0.01% 910
2015
Q2
$21.7M Buy
120,227
+75,148
+167% +$13.6M 0.02% 700
2015
Q1
$7.81M Sell
45,079
-71,269
-61% -$12.4M 0.01% 1144
2014
Q4
$21.5M Buy
116,348
+35,423
+44% +$6.55M 0.01% 693
2014
Q3
$13.4M Buy
80,925
+17,934
+28% +$2.97M 0.01% 889
2014
Q2
$9.84M Sell
62,991
-44,895
-42% -$7.02M 0.01% 1053
2014
Q1
$16.4M Sell
107,886
-89,841
-45% -$13.7M 0.01% 743
2013
Q4
$26.3M Buy
197,727
+34,584
+21% +$4.6M 0.02% 539
2013
Q3
$19M Buy
163,143
+48,336
+42% +$5.61M 0.01% 618
2013
Q2
$10.6M Buy
+114,807
New +$10.6M 0.01% 824